Ameritas Investment Partners, Inc. Homology Medicines, Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.39 - $3.12 $4,174 - $9,369	-3,003 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$12.07 - $19.34 $11,044 - $17,696	915 Added 43.82%	3,003 $46,000
Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $12,184 - $20,145	664 Added 46.63%	2,088 $41,000
Q1 2019 May 15, 2019	BUY	$19.76 - $29.57 $11,065 - $16,559	560 Added 64.81%	1,424 $39,000
Q2 2018 Aug 13, 2018	BUY	$16.49 - $21.55 $14,247 - $18,619	864 New	864 $18,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.